{
  "articles": [
    {
      "pmid": "30000001",
      "title": "Metformin induces AMPK activation and inhibits mTOR signaling in breast cancer cells",
      "abstract": "Preclinical studies demonstrate that metformin activates AMP-activated protein kinase (AMPK), leading to downstream inhibition of mTOR and reduced proliferation in breast cancer cell lines. Synergy with chemotherapy observed in vitro.",
      "year": 2016
    },
    {
      "pmid": "30000002",
      "title": "Population analysis of metformin use and reduced cancer incidence",
      "abstract": "Epidemiological studies show an association between metformin use and lower incidence of several cancers, though confounding by indication and metabolic health remains a concern.",
      "year": 2018
    },
    {
      "pmid": "30000003",
      "title": "Metabolic reprogramming by metformin in colorectal adenomas",
      "abstract": "Clinical biomarker studies show metformin reduces insulin and IGF-1 pathway activity and may decrease adenoma recurrence in hyperinsulinemic patients.",
      "year": 2015
    }
  ]
}
